<DOC>
	<DOCNO>NCT02186522</DOCNO>
	<brief_summary>Patients admit intensive care unit ( ICU ) high risk develop secondary infection , part due dysfunction failure 'germ kill ' function ( immune system ) . Our group recently identify three signature immune system failure readily detect blood sample , importantly , appear predict chance develop secondary infection . Such test would major benefit management patient intensive care translate test usable everyday clinical practice . This study aim validate original finding cohort patient multiple ICUs , use test suitable everyday clinical practice , thus take next step towards develop market-ready test . Study hypothesis : Measurement neutrophil CD88 , monocyte HLA-DR percentage Tregs accurately predict risk nosocomial infection .</brief_summary>
	<brief_title>Immune Failure Critical Therapy ( INFECT ) Study</brief_title>
	<detailed_description />
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Shock , Septic</mesh_term>
	<criteria>Age &gt; 16 ( &gt; 18 England ) Requiring level 3 care ( i.e . require invasive support respiratory system alone , two organ system ( haemofiltration , inotropes/vasopressors ) Predicted remain ICU least 48 hour , Not expect survive 24 hour Known suspected ICUacquired infection time screen ( nonICU acquire nosocomial infection i.e . nonICU healthcare associate infection NOT exclusion ) Known inborn error immune function Immunosuppression ( corticosteroid 400mg hydrocortisone equivalent daily dose permit ) HIV infection Pregnancy Previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Sepsis</keyword>
	<keyword>Septic shock</keyword>
	<keyword>Critical care</keyword>
	<keyword>Immune dysfunction</keyword>
	<keyword>Inflammatory marker</keyword>
	<keyword>Neutrophil</keyword>
	<keyword>Monocyte</keyword>
	<keyword>Tregs</keyword>
</DOC>